Mark Jeffrey Delong - Net Worth and Insider Trading
Mark Jeffrey Delong Net Worth
The estimated net worth of Mark Jeffrey Delong is at least $2 Million dollars as of 2024-11-06. Mark Jeffrey Delong is the Chief Business & Strat Officer of Apellis Pharmaceuticals Inc and owns about 54,693 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $2 Million. Details can be seen in Mark Jeffrey Delong's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Jeffrey Delong has not made any transactions after 2024-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Jeffrey Delong
Mark Jeffrey Delong Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Jeffrey Delong owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .
Click here to see the complete history of Mark Jeffrey Delong’s form 4 insider trades.
Insider Ownership Summary of Mark Jeffrey Delong
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 2024-03-18 | Senior Vice President |
Mark Jeffrey Delong Latest Holdings Summary
Mark Jeffrey Delong currently owns a total of 1 stock. Mark Jeffrey Delong owns 54,693 shares of Apellis Pharmaceuticals Inc (APLS) as of March 18, 2024, with a value of $2 Million.
Latest Holdings of Mark Jeffrey Delong
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals Inc | 2024-03-18 | 54,693 | 28.08 | 1,535,506 |
Holding Weightings of Mark Jeffrey Delong
Mark Jeffrey Delong Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Jeffrey Delong has made a total of 17 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 9,913 shares on March 18, 2024, which brought Mark Jeffrey Delong around $564,050.
Insider Trading History of Mark Jeffrey Delong
- 1
Mark Jeffrey Delong Trading Performance
Mark Jeffrey Delong Ownership Network
Ownership Network List of Mark Jeffrey Delong
Ownership Network Relation of Mark Jeffrey Delong
Mark Jeffrey Delong Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Mark Jeffrey Delong is the Senior Vice President of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Mark Jeffrey Delong made 6 insider transaction in Apellis Pharmaceuticals Inc (APLS) with a net sale of 14,023. Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 308,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .
In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,275,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,275,451 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Mark Jeffrey Delong Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Jeffrey Delong. You might contact Mark Jeffrey Delong via mailing address: 100 5th Avenue, 3rd Floor, Waltham Ma 02451.